Used primarily as an intermediate in the synthesis of sulfonamide-based pharmaceuticals, this compound plays a key role in the development of carbonic anhydrase inhibitors. These inhibitors are applied in the treatment of glaucoma, epilepsy, and certain types of edema. Its structure allows for effective binding to enzyme active sites, enhancing therapeutic efficacy. Additionally, it serves in research settings for developing new bioactive molecules with potential antimicrobial and anti-inflammatory properties.